Skip to main content
NCBI home page
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Pediatr Res. 2011 Aug;70(2):153–158. doi: 10.1203/PDR.0b013e3182225ac9

Live Colonocytes in Newborn Stool: Surrogates for Evaluation of Gut Physiology and Disease Pathogenesis

Dinesh S Chandel 1, Gheorghe T Braileanu 1, June-Home J Chen 1, Hegang H Chen 1, Pinaki Panigrahi 1
PMCID: PMC3140458  NIHMSID: NIHMS301225  PMID: 21544008

Abstract

Studies of gastrointestinal pathophysiology are not feasible by biopsies in human neonates. We examined the utility of live colonocytes in stool in studying cellular markers during early neonatal life. Expression of IgA, IgG, Cluster of Differentiation-45 cells (CD45), Toll-like receptors-2 and 4 (TLR2, TLR4) were analyzed by flow-cytometry. Colonocyte RNA extracts were used in quantitative RealTime-PCR (qRT-PCR) to examine the expression of cytokeratin-19, ribosomal protein-24, and tight-junction (Tj) protein zonula occludens-1 (ZO-1). Colonocyte yield varied between 5×104 to 2×106 cells/g of stool. Meconium samples yielded a highly enriched population of viable cells. Although low, all samples showed CD45-positive cells during the initial weeks of life. Starting as early as day-2, IgA expression was observed in 69% of the cells. Low to moderate expression of IgG was observed with a linear increase as the infants grew. There was an almost total lack of TLR2 staining; however, over 55% of the colonocytes showed TLR4 expression. While high levels of IgA in gut cells may serve as a natural protectant during neonatal period, increased TLR4 may provide a niche for lipopolysacharide (LPS) mediated epithelial damage. Use of stool colonocytes can be a valuable noninvasive approach for studying gut pathophysiology in the neonatal period.

INTRODUCTION

Studies involving gut pathophysiology have traditionally relied on tissue biopsies. Due to the invasiveness, this method is largely unacceptable in human neonates, and has thus limited our ability for further scientific exploration and elucidation of mechanisms of disease. While bulk of information derives from post mortem samples and animal models, prospective and systematic examination of pathophysiologic changes in human neonates have been greatly hampered. Apart from diseases of genetic origin and intrauterine malformations, many other conditions of infectious and inflammatory consequences such as necrotizing enterocolitis (NEC) in premature infants have only been studied after the full blown manifestation of disease (e.g. after surgery) leaving the steps of disease progression and pathogenesis largely unexplored.

Studying gut cellular markers using exfoliated colonocytes described earlier (1–3) has now gained renewed interest due to its noninvasive nature. The concept originated over 50 years ago, but the initial procedure to obtain cells for cytological diagnosis by colorectal irrigation appeared too complicated (4) and was abandoned. During early nineties, Nair et al. described a noninvasive procedure to obtain colonocytes from adult stool using percoll-density gradient centrifugation. The technique allowed recovery of several millions (>40×106/g stool) of viable human colonic cells suitable for investigational or diagnostic purposes as they reflected immediate past history of the gut and its metabolic function (5). Since then, several modifications have been made in the collection medium and purification steps (6,7). Recently, there were attempts to separate colonocytes from stool using immuno-magnetic beads covered with antibody against specific epithelial cell proteins (3,8). Multiple studies have shown feasibility of the colonocyte technique in studying molecular biomarkers of colon cancer (6,7), cancer diagnostics and pathogenesis (9), detection of p53 gene mutations (1,10), and evaluation of the action of bioactive food components on gut epithelia (2).

With the advent of modern molecular techniques during the recent past, there has been growing interests in purifying high quality RNA from colonocytes in order to gain insights of in vivo gene expression patterns (11,12). Several studies have reported on this front. In a study by Davidson et al., realtime-PCR (RT-PCR) analysis of mRNA isolated from exfoliated colonocytes was used effectively to monitor early stage colon cancers and chronic inflammation (11). Another study involving viable colonocytes isolated from adult stool demonstrated disease-related gene expression patterns in vivo (13). However, studies in human neonates, where such approaches may have the maximum benefit, have received extremely limited attention (3,14). In the current study, an attempt was made to isolate and examine colonocytes from infant stools during early neonatal life. To the best of our knowledge, this is the first report describing isolation of large number of viable colonocytes from meconium samples and utility of these cells in flow cytometry for elucidation of surface markers, and recovery of RNA amenable for further molecular studies.

MATERIALS AND METHODS

Patients and samples

Random stool samples (0.5–1.0 g) were collected from diapers of 59 infants admitted to the NICU or step-down unit at University of Maryland Medical Center. Patient identifiers were removed except the gestational age and age of the baby. The NICU staff collecting samples were not involved in the laboratory analysis. Prior informed consents were obtained from one parent and the study was approved by the Institutional Review Board (IRB) at University of Maryland. Although the collection was random, an attempt was made to have samples spread over a wide range of gestational age (24 through 40 weeks) and days of life in the first month. Sample collection was stopped, after banking multiple samples for age groups ranging from day 2–4 (meconium), 7(±2), 14(±3), 21(±3), 28(±3), and 60(±5) days. Detailed flow cytometry analysis was done on a subset of samples representing these age groups.

Isolation of Live colonocytes

Samples were processed using a commercially available kit (Noninvasive technologies Inc. Elkridge, MD) with subtle modifications in collection and purification steps. Briefly, 0.5g of fresh stool scraped from infant diapers was thoroughly suspended (vortexed after adding 5–6 glass-beads) in a cell transport medium (at room-temperature) within one hour of collection. The resulting mix was sequentially filtered through a 330 μm nylon mesh and a 40 μm filter cap, into a 50ml centrifuge tube and subjected to percoll-density gradient centrifugation as per kit protocol. Due to interfering precipitates (casein rich breast milk diet of the newborns) masking the supernatant layers, repeat stringent PBS washes were added to the protocol for effective purification and yield. An aliquot from purified cell suspension was counted following Trypan-blue exclusion under a phase contrast microscope using a hemocytometer to distinguish the viable cell population from necrotic ones. The meconium however, due to sticky and stretchable texture, was difficult to process requiring extra homogenization and filtration steps. Apart from the interface (as recommended by the manufacturer), we retained the upper mucous layer and subjected it to repeat PBS wash and further gradient purifications. Separate aliquots of purified colonocytes were stored frozen (−80°C) in a cell-freezing medium until further use in flow cytometry; and also instantly suspended in RNeasy buffer prior freezing, for future RNA purification and gene expression analysis.

Flow cytometry for IgA, IgG, Cluster of Differentiation-45 cells (CD45), Toll-Like Receptors 2 and 4 (TLR2, TLR4)

Flow cytometry assays and staining for surface antigens on isolated colonocytes were performed as described previously (1). For direct staining of CD45, IgA, and IgG, the fluorescent labeled primary antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA) was added to the cells and incubated at room temperature for 15 minutes (IgA and IgG), or at 4°C for 60 minutes for CD45. For indirect staining for TLR2 and TLR4, cells were initially stained with unlabeled primary antibody and treated with fluorescent secondary antibody. The cells were washed twice in 1% BSA (PBS) to remove unbound antibody conjugate and resuspended in the same buffer for flow cytometry analysis (BD FACS Calibur™, Becton Dickinson Immunocytometry Systems, San Jose, CA).

Isolation of total RNA from Colonocytes and mRNA purification

Frozen aliquots of isolated colonocytes suspended in RNeasy buffer were processed for RNA purification using a kit protocol previously applied in adult samples (12). However, suboptimal RNA yield and contaminating bacterial RNA prompted us to include subtle modifications prior to mRNA enrichment. Samples were subjected to mRNA purification using Oligotex mRNA-mini kit (Qiagen Inc., Valencia, CA) to obtain optimal quality mRNA yield suitable for quantitative realtime-PCR (qRT-PCR) analysis.

Quantitative Realtime-PCR (qRT-PCR)

Quantitative RT-PCR analysis was done for selected genes using our previously described methods (15). Briefly, 100ng of total RNA from each sample was reverse transcribed using the SuperScript-III first Strand Synthesis Supermix for qRT-PCR (Invitrogen, Carlsbad, CA). SYBR Green JumpStart Taq ReadyMix Kit (Sigma, Saint Louis, MS) was applied using an iCycler iQ RT-PCR detection System (Bio-Rad, Hercules, CA). Using colonocyte mRNA from infants (days 2/4, 7, 14 and 28), we amplified the eukaryotic genes: cytokeratin-19: an epithelial cell marker; zonula occludens-1 (ZO-1): a tight junction (Tj) protein; and the ribosomal protein-24: a house keeping mammalian gene. Table-1 lists the primer sets used to amplify these genes for this study. The PCR program included a pre-incubation step at 95°C for 15 min to activate the Taq-polymerase prior to 45 cycles of denaturation (94°C), annealing (56°C) and extension (72°C), each for 30s. Samples were tested in triplicate, and RNA from cultured Caco-2 cells was also included as positive control.

Table 1.

DNA sequence of primer pairs used to study human colonocyte genes.

Genes amplified Description Primer sequence* qRT-PCR (n=cycles)
Ribosomal protein-24 cytoplasmic, 40s ribosomal protein encoded by RPS24-gene F:5′-GATGTCATCTTTGTATTTGGATTC-3′
R:5′-GTCCCCCTGACCTTCTTCATTCTG-3′		 16
Cytokeratin-19 a biomarker, used in RT-PCR detection of tumor cells disseminated in lymph nodes, blood and bone-marrow, and to differentiate cells of epithelial origin, encoded by KRT19-gene F: 5′-ATCCTGAGTGACATGCGAAGC-3′
R: 5′-CATGAGCCGCTGGTACTCCTG-3′		 18
ZO-1 intercellular tight junction protein-1, encoded by TJP1-gene F: 5′-CGGTCCTCTGAGCCTGTAAG-3′
R: 5′-GGATCTACATGCGACGACAA-3′		 20
Open in a new tab
*

F= forward, R=reverse

Statistical analysis

To investigate the association between time and expression of surface markers (and colonocyte yield), we used a straight-line regression model with each marker expression as dependent variable and time as independent variable. A linear trend was indicated when the test of slope was significant (p<0.05). Data analyses were performed using statistics analysis software SAS version 9.2.

RESULTS

Colonocyte Yield

The yield of isolated colonocytes from the neonatal stool varied between 5×104 to 2×106 cells/g of stool. Trypan-blue exclusion showed cellular-integrity and viability in an enriched (70%) population of the exfoliated cells in stool. There was no difference in viability or number of cells extracted based on the gestational age (GA) of the infant. However, instant processing of stool samples within minutes seemed to result in higher (>80%) yield of viable cells; presumably due to gradual drying of stool in the diaper. Although infant diet (Breast vs. Formula-fed) showed no statistical correlation, early meconium samples (day 2 and 4) resulted in a 10–20 fold higher number of viable cells compared to older infants.

Flow cytometry analysis

Cellular staining and estimation by flow-analysis showed increased exfoliation of cells in stool during early days in life. Flow cytometry graphs in figure-1 display a representative isotype staining (subtracted from the measurements) with increased colonocyte expression of IgA and IgG. A very high percentage of cells were found to express IgA (mean 69%) throughout the neonatal period. Low to moderate expression of IgG (mean 24%) was also observed in these neonates. Although IgG appeared to have a linear increase as the age advanced, it did not reach statistical significance (p=0.08). Figure 2 represents flow cytometry plots showing expression of TLR2, TLR4 and CD45 from gut derived cell population. As shown in figure 3, flow-analysis revealed about 8% (range 2–16%) of isolated cell population to be of lymphoid origin (CD45 positive). Compared to the mature infants, there was a trend toward higher CD45 positive cells in the immature population. Strikingly, majority of the exfoliated cells in newborns lacked TLR2 staining, whereas about 55% (range 17–70%) of the cells revealed TLR4 expression (Figure-3).

Figure 1.

Figure 1

Open in a new tab

Histograms show Flow cytometry results for IgA and IgG expression on stool-derived colonocytes from neonates. A representative isotype staining (A) (subtracted from measurements) shows increased colonocyte expression of IgA (B) and linear rise in IgG levels with infant age (C). M1 represents gated population of unstained cells using the isotype control. M2 represents cells gated for positive staining with either IgA-FITC or IgG-FITC antibodies.

Figure 2.

Figure 2

Open in a new tab

Representative flow cytometry dot plots showing expressions of TLR2, TLR4, and CD45. Column 1 shows the forward (FSC) and side scatter (SSC) plots of the isotype control (A, D and G); Column 2 shows the FL1–FL2 plot of isotype staining (control) from which a region gate is drawn (B, E and H), and Column 3 shows the stained sample. In the FL1–FL2 plots in Column 3, a rightward shift into region R1 indicates a FITC signal shift relative to the control, and an upward shift into region R2 indicates a PE signal shift relative to the control. Only a very small percentage of cells (≈1%) were positive for TLR2 (C) in contrast to about 55% showing TLR4 specific staining (F). Moderately low number (≈8%) of CD45+ cells are shown in this infant (I).

Figure 3.

Figure 3

Open in a new tab

Flow cytometry analysis of colonocyte expression: Percentage of positive cells (expression) matched with age of infants. (A) Average yield of colonocytes obtained from stool samples of premature neonates at different time points. Colonocyte yield varied between 5×104 to 2×106 cells/g of stool. Significantly higher number of viable cells were recovered from stool during early days in life and in meconium (p<0.05). (B) Cells showed a trend toward high CD-45 positive cells early in life: demonstrating the presence of intraepithelial lymphocytes and cells of lymphoid origin from possible minor bleeds in the newborn gut. (C) A high percentage of cells were found to express IgA (mean 69%) throughout the neonatal period. (D) Cells showed low to moderate expression of IgG (mean 24%). Although IgG appeared to have a linear increase as the age advanced, it did not reach significance (p=0.08). (E) There was an almost total lack of TLR2 staining in contrast to TLR4 (F), an average of near 55% colonocytes were shown positive.

Quantitative Realtime-PCR (qRT-PCR)

An overview of the target genes amplified using specific primer sequences and average amplification cycles at which fluorescent signals were detected is shown in Table 1. Using colonocyte RNA from infants representing different age groups, qRT-PCR showed amplification of all three genes-cytokeratin-19: a reference marker for epithelial lineage; ZO-1: a tight junction protein; and the ribosomal protein-24: a house keeping mammalian gene, expressed in neonatal colonocytes. Figure-4 shows reproducibility of qRT-PCR with amplification signals of individual samples analyzed for presence of all three genes. Early and specific signals for the presence of cytokeratin-19 expression in all samples consistently demonstrated epithelial lineage of these live cells in stool. Although we observed no differences among samples based on age, these genes could be amplified with high level of specificity using neonatal colonocytes.

Figure 4.

Figure 4

Open in a new tab

Quantitative RealTime-PCR (qRT-PCR) on colonocyte RNA from infant stool samples representing different age-groups. Epithelial lineage specific marker: cytokeratin-19 (A) and the common eukaryotic genes: ribosomal protein-24 (B); and Tight junction protein: ZO-1(C) displayed a range of amplification signals invariably detected between 16–20 cycles. Although no difference was observed among the samples based on age in this preliminary study, qRT-PCR results indicate that these common genes from colonocytes isolated from premature neonates can be amplified with high level of specificity. The multi-curves (fluorescent signals) in all three graphs represent individual sample RNA amplification profiles compared with standard RNA preparations from cultured Caco-2 cells as positive control (+), and PCR negative controls (−) devoid of any amplification target.

DISCUSSION

In this study, we describe a noninvasive method to obtain highly enriched viable population of colonic cells in stool from premature neonates, adopting a modified protocol that can efficiently recover between 5×104 to 2×106 cells/gm of stool. Adding a selective treatment step, early fecal samples including meconium resulted in highly enriched population of live colonic cells compared to older infants. Meconium can be a rich source of these cells making it an attractive noninvasive approach to study markers of intra-uterine and newborn gut maturation.

Colonic epithelial cells once exfoliated into the fecal stream assume a globular shape and are protected by a thick layer of a glycocalyx as observed in ultra-structural studies (1). These cells, appearing functionally “dormant”, can retain their characteristic cell surface antigenic motifs, and may become activated in the presence of appropriate ligands (agonists) (1). The freshly isolated cells reflect a picture of the immediate past history of the gut function and its environment, retaining their original gene expression profiles during transit via colon. The sample transport medium used in our study was originally formulated to preserve the epithelial cells in stool in a viable state for up to 5–6 days at ambient temperature. It is a nontoxic medium that while preserving cell integrity, arrests metabolic activities, DNA replication and mRNA expression, and inhibits nucleases and neuraminidase (1). These cells, shown to express blood group antigens indicate their origin in proximal segments (distal segment do not express Blood group Antigens), and confirms their survival through transit and retention of their regional characteristics (9).

In a recent review comparing human colonocyte studies (5,7–9,16–18) based on percoll-gradient separation and immunomagnetic-bead based assays, Loktionov (13) observed low yield and poor integrity of the isolated cells as a common problem. Although techniques involving immunomagnetic beads appeared to be superior in some reports (8), they lacked optimization with varying results when subjected to DNA/RNA assessment and gut-gene expression analysis (16,17). However, in line with our findings, more recent reports (3,14) now clearly demonstrate that these techniques do offer a reliable platform for extracting nuclear material from the exfoliated cell population in stool to study gut markers in neonates.

Exfoliated colonocytes in adult stool have been shown to be useful in early detection and prognosis of colon cancer (1,7,9). Using colonocyte DNA, Onouchi et al. (10) have performed mutation analysis for early detection of colorectal cancer. Gene sets identified in fecal mRNA from exfoliated cells has enabled investigators to distinguish between breastfed and formula-fed infants (14). Although these studies clearly support the utility of exfoliated colonocytes in stool, gut surface markers in developing newborn gut have not been described using the noninvasive techniques.

The present study of cellular markers by flow cytometry and genetic analysis by qRT-PCR, further support the utility of exfoliated colonocytes in stool as a potential tool to study gut markers in developing neonates. Apart from cytokeratin-19 specific amplification in all samples indicating epithelial origin of isolated colonic cells, we noticed several key observations in this study: 1) Meconium is a very rich source of live colonocytes and can be an ideal sample to study both fetal and newborn gut pathophysiology. 2) Exfoliated cells as early as day-2 express high levels of IgA, with a low to moderate expression of IgG. 3) Intraepithelial lymphocytes are probably the source of the small number of CD45 positive cells in stool, although minor bleeds in the leaky newborn gut cannot be ruled out. 4) Colonocytes of preterm neonates may lack TLR2 expression, however over 55% of the cells expressed TLR4. Also, exfoliated epithelial cells should be distinguished from cells of other (lymphoid) lineages that are unrelated to gut exfoliation. Notably, our observation of CD45 positive cell population, traced as cells of lymphoid origin, can serve as a marker of inflammation and disease.

Colonocytes obtained from early neonatal period (day-2) showed elevated IgA expression. Other prospective studies have shown early physiological increase in salivary IgA in formula-fed than in breast-fed infants (19). This may be a natural protective mechanism against colonizing pathogens in the newborn triggered by yet unknown factors when the formula-fed infant is deprived of breast-milk IgA. However, we also observed a linear rise in IgG levels in these cells, with infants’ age, probably due to exposure to the colonizing microbes in the gut. It is logical to speculate that exposure to bacterial world, during early infancy may have a significant impact on IgA and IgG expression later in life.

Using Flow cytometry, Nair et al. (1) first described functional diversity of colonocytes purified from adult stool showing surface expression of IgG, IgA and the secretory component. Expression of IgG have also been reported in colonic cancer cells (20,21). Previous studies with cultured epithelial cells have shown surface expression of Fc fragment of IgG (IgG-Fc) binding sites (22,23). The intestinal epithelial cells (IECs), as non-professional antigen presenting cells (APC), can take up and process antigens activating CD8+ regulatory T-cell subsets in a non-classical Major Histocompatibility Complex-1 (MHC I) restricted manner (24). The IECs work as the first line of defense against the heavy load of bacteria in the gut. These cells have been shown to constitutively and inducibly express several functional TLRs (25) in vitro and in vivo, including TLR2 (ligands e.g.: peptidoglycan, lipoproteins), TLR4 (Lipopolysacharide (LPS)), and TLR9 (methylated sequences in DNA significant in gene regulation (CpG DNA)) (26–28). In a recent study in wild-type mice, differential expression of colonic TLR2 and TLR4 along the proximal-distal axis, has been mainly attributed to significant differences in the community structure and diversity of mucosa-associated microbiota located in the distal and proximal colon (29).

Cario et. al. (30) have shown that colonocytes of preterm neonates may lack TLR2 expression and may be vulnerable to tight junctions damage. However, high level of TLR4 expression may further provide a suitable niche for Gram-negative or lipopolysacharide (LPS) mediated damage in these cells. Fusunyan and colleagues (31) have described constitutive expression of TLR 2 and TLR 4 on the basolateral surface of fetal crypt enterocytes (H4 small intestinal cells). In their study, IL-1β increased both TLR 2 and TLR 4 whereas LPS decreased TLR 4 in these enterocyte-like H4 cells (31). More recently, direct involvement of TLRs and Nucleotide-binding Oligomerization Domain-2 (NOD2) has been shown in NEC (32). Activation of TLR2 leads to enhancement of ZO-1 associated intestinal epithelial barrier integrity (33). Oral supplementation with TLR2 ligand Proprotein Convertase Subtilisin/Kexin (PCSK) significantly suppressed mucosal inflammation and apoptosis by restoring tight junction (Tj) integrity in this study. Other TLR2 inducing Gram positive commensals and probiotics have also been reported in maintaining intestinal mucosal homeostasis against tissue injury (34–37)

In conclusion, our study highlights a noninvasive method for purifying viable colonic cells from stool of neonates. Higher number of these cells recovered in early stool and meconium samples, further substantiates utility of these cells in designing post-natal screening/diagnostic tests for the study of neonatal gut maturation. Isolated colonocytes can be used for the detection of the surface antigens by flow cytometry and the study of gene expression by RT-PCR. Gene expression analysis can help monitor group of genes, whose expression changes early in gut maturation and disease onset, during postnatal life. Larger studies on these colonic cells, exploring multi-target assay panels and gene-expression signature patterns, may allow molecular classifications of gut maturation and disease pathogenesis. Future expression microarray and epigenetic approaches involving colonic cells, and studies targeting gut specific responses to bacterial colonization comparing healthy and inflamed gut, may provide clues to pathogenic insights and disease progression in developing human neonates.

Acknowledgments

This study was funded in part by the NIH grant RO1HD53719.

ABBREVIATIONS

CD45

Cluster of Differentiation-45 cells

LPS

Lipopolysacharide

qRT-PCR

quantitative RealTime-PCR

TLR2/4

Toll-Like Receptor 2 or 4

ZO-1

zonula occludens-1 (a tight junction(Tj)-protein)

References

  • 1.Nair P, Lagerholm S, Dutta S, Shami S, Davis K, Ma S, Malayeri M. Coprocytobiology: on the nature of cellular elements from stools in the pathophysiology of colonic disease. J Clin Gastroenterol. 2003;36:S84–S93. doi: 10.1097/00004836-200305001-00015. [DOI] [PubMed] [Google Scholar]
  • 2.Kamra A, Kessie G, Chen JH, Kalavapudi S, Shores R, McElroy I, Gireesh T, Sudhakaran PR, Dutta SK, Nair PP. Exfoliated colonic epithelial cells: surrogate targets for evaluation of bioactive food components in cancer prevention. J Nutr. 2005;135:2719–2722. doi: 10.1093/jn/135.11.2719. [DOI] [PubMed] [Google Scholar]
  • 3.Kaeffer B, des Robert C, Alexandre-Gouabau MC, Pagniez A, Amarger V, Legrand A, Kuster A, Piloquet H, Champ M, Le Huarou-Luron I, Roze J-C. Recovery of exfoliated cells from the gastrointestinal tract of premature infants: a new tool to perform “noninvasive biopsies? Pediatr Res. 2007;62:564–569. doi: 10.1203/PDR.0b013e318155a402. [DOI] [PubMed] [Google Scholar]
  • 4.Bader GM, Papanicolaou GN. The application of cytology in the diagnosis of cancer of the rectum, sigmoid, and descending colon. Cancer. 1952;5:307–314. doi: 10.1002/1097-0142(195203)5:2<307::aid-cncr2820050217>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  • 5.Iyengar V, Albaugh GP, Lohani A, Nair PP. Human stools as a source of viable colonic epithelial cells. FASEB J. 1991;5:2856–2859. doi: 10.1096/fasebj.5.13.1655550. [DOI] [PubMed] [Google Scholar]
  • 6.Lagerholm S, Dutta S, Nair PP. Noninvasive detection of c-myc p64, c-myc p67 and c-erbb-2 in colorectal cancer. Scand J Gastroenterol. 2005;40:1343–1350. doi: 10.1080/00365520510023549. [DOI] [PubMed] [Google Scholar]
  • 7.Yamao T, Matsumura Y, Shimada Y, Moriya Y, Sugihara K, Akasu T, Fujita S, Kakizoe T. Abnormal expression of CD44 variants in the exfoliated cells in the feces of patients with colorectal cancer. Gastroenterology. 1998;114:1196–1205. doi: 10.1016/s0016-5085(98)70425-1. [DOI] [PubMed] [Google Scholar]
  • 8.Matsushita H, Matsumura Y, Moriya Y, Akasu T, Fujita S, Yamamoto S, Onouchi S, Saito N, Sugito M, Ito M, Kozu T, Minowa T, Nomura S, Tsunoda H, Kakizoe T. A new method for isolating colonocytes from naturally evacuated feces and its clinical application to colorectal cancer diagnosis. Gastroenterology. 2005;129:1918–1927. doi: 10.1053/j.gastro.2005.10.007. [DOI] [PubMed] [Google Scholar]
  • 9.Albaugh GP, Iyengar V, Lohani A, Malayeri M, Bala S, Nair PP. Isolation of exfoliated colonic epithelial cells, a novel noninvasive approach to the study of cellular markers. Int J Cancer. 1992;52:347–350. doi: 10.1002/ijc.2910520303. [DOI] [PubMed] [Google Scholar]
  • 10.Onouchi S, Matsushita H, Moriya Y, Akasu T, Fujita S, Yamamoto S, Hasegawa H, Kitagawa Y, Matsumura Y. New method for colorectal cancer diagnosis based on SSCP analysis of DNA from exfoliated colonocytes in naturally evacuated feces. Anticancer Res. 2008;28:145–150. [PubMed] [Google Scholar]
  • 11.Davidson LA, Lupton JR, Miskovsky E, Fields AP, Chapkin RS. Quantification of human intestinal gene expression profiles using exfoliated colonocytes: a pilot study. Biomarkers. 2003;8:51–61. doi: 10.1080/1354750021000042268. [DOI] [PubMed] [Google Scholar]
  • 12.Ahmed FE, James SI, Lysle DT, Dobbs LJ, Johnke RM, Flake G, Stockton P, Sinar DR, Naziri W, Evans MJ, Kovacs CJ, Allison RR. Improved methods for extracting RNA from exfoliated human colonocytes in stool and RT-PCR analysis. Dig Dis Sci. 2004;49:1889–1898. doi: 10.1007/s10620-004-9589-9. [DOI] [PubMed] [Google Scholar]
  • 13.Loktionov A. Cell exfoliation in the human colon: myth, reality and implications for colorectal cancer screening. Int J Cancer. 2007;120:2281–2289. doi: 10.1002/ijc.22647. [DOI] [PubMed] [Google Scholar]
  • 14.Chapkin RS, Zhao C, Ivanov I, Davidson LA, Goldsby JS, Lupton JR, Mathai RA, Monaco MH, Rai D, Russell WM, Donovan SM, Dougherty ER. Noninvasive stool-based detection of infant gastrointestinal development using gene expression profiles from exfoliated epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2010;298:G582–G589. doi: 10.1152/ajpgi.00004.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Panigrahi P, Braileanu GT, Chen H, Stine OC. Probiotic bacteria change Escherichia coli-induced gene expression in cultured colonocytes: Implications in intestinal pathophysiology. World J Gastroenterol. 2007;13:6370–6378. doi: 10.3748/wjg.v13.i47.6370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Loktionov A, O’Neill IK, Silvester KR, Cummings JH, Middleton SJ, Miller R. Quantitation of DNA from exfoliated colonocytes isolated from human stool surface as a novel noninvasive screening test for colorectal cancer. Clin Cancer Res. 1998;4:337–342. [PubMed] [Google Scholar]
  • 17.Bandaletova T, Bailey N, Bingham SA, Loktionov A. Isolation of exfoliated colonocytes from human stool as a new technique for colonic cytology. APMIS. 2002;110:239–246. doi: 10.1034/j.1600-0463.2002.100306.x. [DOI] [PubMed] [Google Scholar]
  • 18.Spethmann S, Fisher C, Wagener C, Streichert T, Tschentscher P. Nucleic acids from intact epithelial cells as a target for stool-based molecular diagnosis of colorectal cancer. Int J Mol Med. 2004;13:451–454. [PubMed] [Google Scholar]
  • 19.Brandtzaeg P, Nilssen DE, Rognum TO, Thrane PS. Ontogeny of the mucosal immune system and IgA deficiency. Gastroenterol Clin North Am. 1991;20:397–439. [PubMed] [Google Scholar]
  • 20.Qiu X, Zhu X, Zhang L, Mao Y, Zhang J, Hao P, Li G, Lv P, Li Z, Sun X, Wu L, Zheng J, Deng Y, Hou C, Tang P, Zhang S, Zhang Y. Human epithelial cancers secrete immunoglobulin-G with unidentified specificity to promote growth and survival of tumor cells. Cancer Res. 2003;63:6488–6495. [PubMed] [Google Scholar]
  • 21.Chen Z, Gu J. Immunoglobulin G expression in carcinomas and cancer cell lines. FASEB J. 2007;21:2931–2938. doi: 10.1096/fj.07-8073com. [DOI] [PubMed] [Google Scholar]
  • 22.Kobayashi K, Brown WR. Study of colonic IgG Fc binding site in cultured epithelial cells. Dig Dis Sci. 1994;39:526–533. doi: 10.1007/BF02088337. [DOI] [PubMed] [Google Scholar]
  • 23.Harada N, Iijima S, Kobayashi K, Yoshida T, Brown WR, Hibi T, Oshima A, Morikawa M. Human IgGFc binding protein (FcγBP) in colonic epithelial cells exhibits mucin-like structure. J Biol Chem. 1997;272:15232–15241. doi: 10.1074/jbc.272.24.15232. [DOI] [PubMed] [Google Scholar]
  • 24.Perera L, Shao L, Patel A, Evans K, Meresse B, Blumberg R, Geraghty D, Groh V, Spies T, Jabri B, Mayer L. Expression of non-classical class I molecules by intestinal epithelial cells. Inflamm Bowel Dis. 2007;13:298–307. doi: 10.1002/ibd.20026. [DOI] [PubMed] [Google Scholar]
  • 25.Cario E. Toll-like receptors and gastrointestinal diseases: from bench to bedside? Curr Opin Gastroenterol. 2002;18:696–704. doi: 10.1097/00001574-200211000-00011. [DOI] [PubMed] [Google Scholar]
  • 26.Abreu MT, Arnold ET, Thomas LS, Gonsky R, Zhou Y, Hu B, Arditi M. TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J Biol Chem. 2002;277:20431–20437. doi: 10.1074/jbc.M110333200. [DOI] [PubMed] [Google Scholar]
  • 27.Akhtar M, Watson JL, Nazli A, Mckay DM. Bacterial DNA evokes epithelial IL-8 production by a MAPK-dependent, NF-kappaB-independent pathway. FASEB J. 2003;17:1319–1321. doi: 10.1096/fj.03-0950fje. [DOI] [PubMed] [Google Scholar]
  • 28.Cario E, Brown D, McKee M, Lynch-Devaney K, Gerken G, Podolsky DK. Commensal-associated molecular patterns induce selective toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium. Am J Pathol. 2002;160:165–173. doi: 10.1016/S0002-9440(10)64360-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Wang Y, Devkota S, Musch MW, Jabri B, Nagler C, Antonopoulos DA, Chervonsky A, Chang EB. Regional mucosa-associated microbiota determine physiological expression of TLR2 and TLR4 in murine colon. PLoS ONE. 2010;5:e13607. doi: 10.1371/journal.pone.0013607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology. 2007;132:1359–1374. doi: 10.1053/j.gastro.2007.02.056. [DOI] [PubMed] [Google Scholar]
  • 31.Fusunyan RD, Nanthakumar NN, Baldeon ME, Walker WA. Evidence for an innate immune response in the immature human intestine: Toll-like receptors on fetal enterocytes. Pediatr Res. 2001;49:589–593. doi: 10.1203/00006450-200104000-00023. [DOI] [PubMed] [Google Scholar]
  • 32.Le Mandat Schultz A, Bonnard A, Barreau F, Aigrain Y, Pierre-Louis C, Berrebi D, Peuchmaur M. Expression of TLR-2, TLR-4, NOD2 and pNF-kappaB in a neonatal rat model of necrotizing enterocolitis. PLoS One. 2007;2:e1102. doi: 10.1371/journal.pone.0001102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 enhances ZO-1 associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology. 2004;127:224–238. doi: 10.1053/j.gastro.2004.04.015. [DOI] [PubMed] [Google Scholar]
  • 34.Rakoff-Nahoum S, Paglono J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell. 2004;118:229–241. doi: 10.1016/j.cell.2004.07.002. [DOI] [PubMed] [Google Scholar]
  • 35.Otte JM, Podolsky DK. Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Am J Physiol Gastrointest Liver Physiol. 2004;286:G613–G626. doi: 10.1152/ajpgi.00341.2003. [DOI] [PubMed] [Google Scholar]
  • 36.Madsen KL. The use of probiotics in gastrointestinal disease. Can J Gastroenterol. 2001;15:817–822. doi: 10.1155/2001/690741. [DOI] [PubMed] [Google Scholar]
  • 37.Petrof EO, Kojima K, Ropeleski MJ, Musch MW, Tao Y, De Simone C, Chang EB. Probiotics inhibit nuclear factor Kappa B and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology. 2004;127:1474–1487. doi: 10.1053/j.gastro.2004.09.001. [DOI] [PubMed] [Google Scholar]

RESOURCES